Search Videos and More
News
A RACE AGAINST TIME AND DISEASE
“We’ve made great strides treating melanoma at Fox Chase and have built one of the most comprehensive multidisciplinary teams in the region—an expertise recognized nationally and internationally,” says Jeffrey M. Farma, MD, FACS, Chair and Professor, Department of Surgery, Fox Chase Cancer Center. “I’m thrilled to bring TIL (tumor-infiltrating lymphocyte) therapy to our metastatic melanoma patients who are not responding to their first-line treatment—a cellular therapy which requires critical timing and a highly specialized multidisciplinary team to deliver it.”
News
Aiming to Refine NSCLC Targeted Therapy
The first study to prospectively examine the impact of co-mutation biomarkers on sotorasib, a novel targeted therapy, for advanced KRAS G12C mutated NSCLC
News
Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment
News
A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases
Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a hepatic artery infusion (HAI) pump along with standard chemotherapy. Fox Chase is the only local hospital offering this trial, which is designed for patients with colorectal cancer that has spread to the liver and cannot be treated with surgery.
News
Forward Celebrates Fox Chase's 50 Years
Join us on a journey that commemorates the golden anniversary of Fox Chase Cancer Center. Learn about our milestones and achievements that have changed the world of cancer care. Meet the extraordinary clinicians and researchers who made it happen.
News
“Being Present” for My Patients and Staff Is Fundamental to Excellent Care
Clinical Nurse Manager Tatiana Villamarin, BSN, RN, commands important roles within the world of the Fox Chase – Temple Urologic Institute: In one role, Villamarin serves as a high-level administrator-manager for two urology outpatient clinics, overseeing care and coordination for 80 to 100 patients every weekday.
News
Soaring to New Heights: Fox Chase Leadership, Faculty, Residents, and Fellows
A hallmark of Fox Chase leadership, fellows, residents and faculty is their ability to persevere—to keep climbing the often-difficult ascent of cancer discovery and delivery—no matter what. Meet some of the exceptional researchers, scientists, and clinicians determined to make decisive inroads in cancer care.
News
Philadelphia Magazine Names 142 Fox Chase Cancer Center Physicians "Top Doctors"
One hundred and forty-two Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2025. Physicians on the list were nominated by a national survey of their professional peers.
News
Three Fox Chase Cancer Center Faculty Named to 2024 List of World’s Most Highly Cited Researchers
Fox Chase Cancer Center’s?Hossein Borghaei, DO, MS,?Elizabeth Plimack, MD, MS, and Lorenzo Galluzzi, PhD, have been named to the 2024 list of Highly Cited Researchers by Clarivate, a leading global provider of transformative intelligence.
News
Fox Chase Cancer Center Earns Renewal of Prestigious Core Grant from the National Cancer Institute
Fox Chase Cancer Center, part of the Temple Health, has received a five-year renewal of its prestigious Cancer Center Support Grant (CCSG) from the National Cancer Institute (NCI), reaffirming its designation as an NCI-designated Comprehensive Cancer Center—an elite status held by only 57 centers nationwide.
News
Bonds That Last a Lifetime for a Fox Chase Fellow
When I arrived, I clicked right away with Jeffrey M. Farma, MD, FACS, now Chair of the Department of Surgery.
Symposium
23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.